Comparison of IMA Versus CTN-I In Acute Chest Pain Patients for Early Diagnosis of Myocardial Ischemia in Emergency Department

Authors: Jai Parkash Panjwani, Khemomal A. Karira, Jagdesh, Muhammed Iltaf, Muhammed Yousif Memon

1 BAQAI MEDICAL UNIVERSITY, KARACHI, PAKISTAN.
2 SIR SYED COLLEGE OF MEDICAL SCIENCES, KARACHI, PAKISTAN.
4 BHITAI DENTAL & MEDICAL COLLEGE, MIRPURKHAS, PAKISTAN.
4 BASIC MEDICAL SCIENCES INSTITUTE, JINNAH POSTGRADUATE MEDICAL CENTRE, KARACHI, PAKISTAN.
5 LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES, JAMSHORO, PAKISTAN.

Volume 19 | Issue 1

Published: November 6, 2026

Abstract

To evaluate the serum level of ischemia modified albumin (IMA) and cardiac troponin-I in patients with chest pain admitted in emergency department of NICVD for early diagnosis of ischemic heart disease prone to myocardial infarction by observing the sensitivity and specificity of coronary heart disease. Material and Methods: Present study was carried out in the Department of Biochemistry, BMSI, JPMC; in collaboration of National Institute of Cardiovascular Diseases (NICVD) Karachi. 228 patients out of 1050 were randomly selected who have continuously chest pain for three hours and were divided in three groups. In Group-A patients having chest pain continuously for three hours with normal ECG and Troponin-I (n = 66), Group-B patients with chest pain have developed ECG changes within three hours (n = 72), Group-C patients with chest pain followed by myocardial infarction with increased Troponin-I (n = 90), in addition 54 normal healthy controls subjects were taken from general population for comparison. Results: The result showed that the mean values of ischemia modified albumin (IMA) in healthy subjects were 22.40 ± 1.46, and in three groups of patients were 40.0 ± 2.79, 85.52 ± 2.10 and 95.31 ± 1.66 respectively. When these values were compared to each other group-A showed statistically significant difference with control, while group-B showed statistically significant difference (p < 0.01) with normal control and group-A, where as group-C showed statistically significant difference with normal control and group-A and B. Similarly the mean cTn-I values were 0.12 ± 0.01, 0.13 ± 0.01, 0.41 ± 0.01 and 0.63 ± 0.01 respectively. When these values were compared with each other, group-B showed statistically significant difference (p < 0.01) with normal control and group-A, where as group-C showed statistically significant difference with normal control and group-A and B. The sensitivity and specificity among chest pain with normal ECG subjects was 18.2 % and 25.9 %, while chest pain patients with ECG changes showed 62.5 % and 44.2 %; where as in chest pain with M.I. and increased cTn-I subjects was 83.3 % and 58.7 % respectively. Thus sensitivity of IMA > 85 U/ml confirmed that these chest pain patients having angina later will prone ECG changes and may progress to myocardial infarction. Conclusion: We strongly recommended that serum IMA level should be routinely performed at the time of admission in combination with measurement of cardiac troponinI and ECG, to confirm or exclude a final diagnosis of ischemic heart disease and to exclude myocardial infarction.

Keywords: IMA, cTn1, ECG, CHD, IHD

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF